TCP1P3

Across TCGA pan-cancer cohorts, TCP1P3 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of TCP1P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where TCP1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TCP1P3 is over-expressed in tumor.

COAD, LUSC, and HNSC are the cancer types where TCP1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TCP1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.520	<.001	6	view →
LUSC	All	All	+0.081	.002	5	view →
HNSC	Male	All	+0.074	.005	4	view →
ESCA	Male	All	+0.337	.010	2	view →
STAD	All	All	+0.116	.030	2	view →
LUAD	All	All	+0.090	.007	2	view →
PRAD	All	All	+0.059	.003	2	view →
LIHC	All	All	+0.363	.024	1	view →
CHOL	All	All	+0.147	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

TCP1P3–COAD

Open the COAD breakdown →